These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8711161)

  • 1. [The presence of antibodies against Francisella tularensis among inhabitants of North-Eastern Poland].
    Hermanowska-Szpakowicz T; Pancewicz SA
    Przegl Epidemiol; 1996; 50(1-2):55-9. PubMed ID: 8711161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should ticks be regarded as a tularemia vector in habitants of North-Eastern Poland?].
    Pancewicz SA; Zajkowska JM; Swierzbińska R; Kondrusik M; Grygorczuk SS; Hermanowska-Szpakowicz T
    Med Pr; 2004; 55(2):189-92. PubMed ID: 15524088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of tularemia seroprevalence in the rural area of Thrace region in Turkey].
    Dedeoğlu Kilinç G; Gürcan S; Eskiocak M; Kiliç H; Kunduracilar H
    Mikrobiyol Bul; 2007 Jul; 41(3):411-8. PubMed ID: 17933252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of intradermally administered tularin Sevac on the titre of slow agglutination reaction with the Francisella tularensis antigen (author's transl)].
    Cerný Z
    Cesk Epidemiol Mikrobiol Imunol; 1975 Nov; 24(6):337-43. PubMed ID: 130981
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of antibodies to Francisella tularensis in forest workers from different regions of Poland].
    Rastawicki W; Kurowska J; Hermanowska-Szpakowicz T; Pancewicz SA; Kondrusik M; Jagielski M
    Med Dosw Mikrobiol; 2006; 58(3):207-15. PubMed ID: 17340995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies to Francisella tularensis in cats.
    Magnarelli L; Levy S; Koski R
    Res Vet Sci; 2007 Feb; 82(1):22-6. PubMed ID: 16914176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum immunoglobulin IgG subclass distribution of antibody responses to Francisella tularensis in patients with tularemia].
    Rastawicki W; Rokosz-Chudziak N; Wolaniuk N
    Med Dosw Mikrobiol; 2014; 66(1):11-5. PubMed ID: 25007508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of antibodies of Borrelia burgdorferi among inhabitants of north-eastern Poland].
    Pancewicz SA; Januszkiewicz A; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 1996; 50(4):375-81. PubMed ID: 9132793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreaks of tularemia in Turkey.
    Sahin M; Atabay HI; Bicakci Z; Unver A; Otlu S
    Kobe J Med Sci; 2007; 53(1-2):37-42. PubMed ID: 17579300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence study of Francisella tularensis among hunters in Germany.
    Jenzora A; Jansen A; Ranisch H; Lierz M; Wichmann O; Grunow R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):183-9. PubMed ID: 18462387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D; Rhinehart-Jones TR; Elkins KL
    J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of a serological micromethod for the detection of antibodies against Francisella tularensis].
    Nunes MP; Ricciardi ID
    An Microbiol (Rio J); 1980; 25():61-7. PubMed ID: 6982628
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.
    Raynaud C; Meibom KL; Lety MA; Dubail I; Candela T; Frapy E; Charbit A
    Infect Immun; 2007 Jan; 75(1):536-41. PubMed ID: 17030571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of antibodies against Francisella tularensis in Castilla y León (Spain) before 1997].
    Gutiérrez MP; Orduña A; Dueñas A; Bratos MA; Almaraz A; Alamo R; Rodríguez Recio MJ; Rodríguez Marcos H; Rodríguez Torres A
    Med Clin (Barc); 2003 Feb; 120(3):97-8. PubMed ID: 12605730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.